期刊文献+

29例复发性子宫内膜癌的临床分析 被引量:2

The clinical analysis of 29 cases of recurrent endometrial carcinoma
下载PDF
导出
摘要 目的 :探讨子宫内膜癌治疗后复发的原因及其合理的治疗方法。方法 :对 1976~ 1993年收治的 2 9例复发性子宫内膜癌患者的临床资料进行回顾性分析。结果 :3年内复发者占 82 .8% (2 4 / 2 9) ,复发部位以阴道残端最常见 ,占 34.5% (10 / 2 9)。复发后再治疗的 2 5例中 ,6例存活 5年以上 ,未经治疗的 4例均在半年内死亡。结论 :首次治疗方式是影响复发的主要原因。子宫内膜癌应手术配合放疗 ,且术后 3年内应严密随诊 ,复发后再治疗对延长病人生存时间是有意义的 ,放射治疗是复发后的主要治疗手段。 Objective:Analysis the cause of relaspse of uterine endometrial carcinoma after operation and other treatment.Methods:retrospective study were performed in 29 patients with recurret endometrial carcinoma in our hospital from 1976 to 1993.Results:3 months to 6 years after first clinical cure,29 cases relapsed.Recurrence and metastasis were found at vagina、lung、bone、pelvis and abdomen and so on.Among the 29 cases,first diagnosed as stage Ⅰ was 19,stage Ⅱ was 6 and stage Ⅲ was 4.The pathologic types were 21 with adenocarcinoma,3 with adenosquamous carcinoma,1 with clear cell carcinoma,2 with pappiloma adenocarcinoma and adenoacanthoma respectively.Conclusions:we analysis the causes of recurrence,in order to keep our eyes on the high risk factors which can cause recurrence,and explore the appropriate first treatment mode so as to reduce recurrence and treatment number after recurrence,improve the prognosis of endometrial carcinoma.
出处 《肿瘤防治杂志》 2000年第2期169-170,共2页 China Journal of Cancer Prevention and Treatment
关键词 子宫内膜癌 复发 治疗 预后 endometrial carcinoman recurrence therapy prognosis
  • 相关文献

参考文献7

二级参考文献1

共引文献25

同被引文献34

  • 1屠铮,商宇红,富琪,王建六,魏丽惠.Ⅰ、Ⅱ期子宫内膜癌复发病例的特征与预后[J].中国妇产科临床杂志,2003,4(2):113-116. 被引量:3
  • 2王志启,王建六,刘凤婷,赵丹,高敏,魏丽惠.化疗在复发子宫内膜癌治疗中的作用[J].中华医学杂志,2006,86(13):896-900. 被引量:2
  • 3王建六.应重视子宫内膜癌的激素治疗[J].中国医刊,2007,42(3):7-8. 被引量:5
  • 4Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin,2005,55 : 10-30. 被引量:1
  • 5Mikuta JJ. International federation of gynecology and obstetrics staging of endometrial cancer 1988, Cancer, 1993,71:1460-1463. 被引量:1
  • 6Feltmate CM, Duska LR, Chang Y, et al. Predictors of recurrence in surgical stage Ⅱ endometrial adenocarcinoma. Gynecol Oncol,1999,73:407-411. 被引量:1
  • 7Wylie J, Irwin C, Pintilie M, et al. Results of radical radiotherapy for recurrent endometrial cancer. Gynecol Oncol,2000 ,77 :66-72. 被引量:1
  • 8Hall DJ, Martin DA, Kincaid K. Filgrastim support during combination chemotherapy using cisplatin, doxorubicin, and cyclophosphamide to treat advanced or recurrent endometrial cancer:a clinical study and literature review. Eur J Gynaecol Oncol,2003,24:481-489. 被引量:1
  • 9Burke TW, Stringer CA, Meads M, et al. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin,doxorubicin, and cyclophosphamide. Gynecol Oncol,1991,40:264-267. 被引量:1
  • 10Fleming GF, Brunetto VL, Celia D, et al. Phase Ⅲ trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol,2004,22:2159-2166. 被引量:1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部